In vivo longitudinal evaluation of vertebral bone strength in patients with rheumatoid arthritis treated with alendronate [alendronic acid]
Phase of Trial: Phase II
Latest Information Update: 13 Sep 2007
At a glance
- Drugs Alendronic acid (Primary)
- Indications Postmenopausal osteoporosis; Rheumatoid arthritis
- Focus Pharmacodynamics; Therapeutic Use
- 13 Sep 2007 New trial record.